JP2005022973A - ムチン含有医薬組成物 - Google Patents

ムチン含有医薬組成物 Download PDF

Info

Publication number
JP2005022973A
JP2005022973A JP2001167149A JP2001167149A JP2005022973A JP 2005022973 A JP2005022973 A JP 2005022973A JP 2001167149 A JP2001167149 A JP 2001167149A JP 2001167149 A JP2001167149 A JP 2001167149A JP 2005022973 A JP2005022973 A JP 2005022973A
Authority
JP
Japan
Prior art keywords
group
mucin
pharmaceutical composition
composition according
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001167149A
Other languages
English (en)
Japanese (ja)
Inventor
Makoto Kawamura
誠 川村
Kazuo Watanabe
和夫 渡辺
Hiroyuki Matsui
裕之 松井
Hiroaki Fukamizu
啓朗 深水
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Pharma Corp
Original Assignee
Mitsubishi Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Pharma Corp filed Critical Mitsubishi Pharma Corp
Priority to JP2001167149A priority Critical patent/JP2005022973A/ja
Priority to PCT/JP2002/005261 priority patent/WO2002098401A1/fr
Publication of JP2005022973A publication Critical patent/JP2005022973A/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2001167149A 2001-06-01 2001-06-01 ムチン含有医薬組成物 Pending JP2005022973A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2001167149A JP2005022973A (ja) 2001-06-01 2001-06-01 ムチン含有医薬組成物
PCT/JP2002/005261 WO2002098401A1 (fr) 2001-06-01 2002-05-30 Composition medicinale comprenant de la mucine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001167149A JP2005022973A (ja) 2001-06-01 2001-06-01 ムチン含有医薬組成物

Publications (1)

Publication Number Publication Date
JP2005022973A true JP2005022973A (ja) 2005-01-27

Family

ID=19009576

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001167149A Pending JP2005022973A (ja) 2001-06-01 2001-06-01 ムチン含有医薬組成物

Country Status (2)

Country Link
JP (1) JP2005022973A (fr)
WO (1) WO2002098401A1 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1171336A (ja) * 1997-06-25 1999-03-16 Mitsubishi Chem Corp アミド誘導体
KR100460173B1 (ko) * 1998-12-11 2004-12-04 겐 코오포레이션 헬리코박터 파일로리 정착 억제제

Also Published As

Publication number Publication date
WO2002098401A1 (fr) 2002-12-12

Similar Documents

Publication Publication Date Title
CN101102761B (zh) 木酚素类化合物用于治疗或预防炎症性疾病的用途
US6030953A (en) Pharmaceutical composition containing chitosan
ES2899372T3 (es) Combinación de tratamiento del cáncer de próstata, composición farmacéutica y método de tratamiento
ES2547379T3 (es) Utilización de calcitonina para el tratamiento de la AR
CN1251091A (zh) 新化合物
CN106470679A (zh) 用半胱天冬酶抑制剂治疗慢性肝脏疾病并发症
RU2227033C2 (ru) Тауролидин и/или таурултам при лечении инфекционной язвенной болезни или инфекционного гастрита
JPS62228026A (ja) 免疫増強剤
JPH0692850A (ja) 胃腸障害治療薬
KR20230018351A (ko) 렘데시비르와 면역조절제 병용투여법을 통한 자가면역류마티스 질환 치료용 조성물
JPH06501944A (ja) Ｎ−（２−アルキル−３−メルカプトグルタリル）−アミノ−ジアザシクロアルカノン誘導体およびそれらのコラゲナーゼ抑制薬としての使用
EP4122483A1 (fr) Composition pharmaceutique orale
JP2004002320A (ja) 生体内で相転移する液状マトリックスおよび液状経口製剤
JP2005022973A (ja) ムチン含有医薬組成物
JPH1171336A (ja) アミド誘導体
JP2008255008A (ja) 滑膜細胞増殖抑制剤
CN109730988A (zh) 1，3-丙二磺酸或其药学上可接受的盐用于治疗肉样瘤病的用途
JP2021533144A (ja) 疼痛及び／又は発熱を予防及び／又は治療するための薬物、組成製品及びその応用
US6348492B1 (en) Oxetanone derivatives
US6342519B2 (en) Oxetanone derivatives
JP2002265354A (ja) 抗ピロリ菌剤組成物
CN115487177B (zh) 一种黄酮类化合物用于治疗溃疡性结肠炎的新用途
EA007863B1 (ru) Применение дистронциевой соли 2-[n,n-ди(карбоксиметил)амино]-3-циано-4-карбоксиметилтиофен-5-карбоновой кислоты при получении лекарственных средств, предназначенных для лечения гастродуоденальной боли
JP5060136B2 (ja) 血管内皮細胞接着分子の発現抑制及び単球遊走因子の産生抑制剤
JP2006131555A (ja) 制酸剤組成物

Legal Events

Date Code Title Description
RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20070427